Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Restricted cash
Other long-term assets
Total assets
Liabilities and stockholders' equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Short-term licensing fees payable
Accrued indemnification obligation
Total current liabilities
Other long-term liabilities
Long-term liabilities
Total liabilities
Common stock; par value $0.0001 per share, 100,000 shares authorized, 36,810 shares issued and outstanding at March 31, 2018; 32,090 shares issued and outstanding at December 31, 2017
Additional paid-in capital
Accumulated deficit
Stockholders’ equity
Class D Preferred Stock
Class C Preferred Stock
Class B-1 Preferred Stock
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support